ALVOTECH |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.35 USD | 0.00% |
|
+41.42% | +42.32% |
| 30/04 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
| 30/04 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALVOTECH | Other Biotechnology & Medical Research | 0.00% | +41.42% | +42.32% | - | - | 3.73B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock
- Charts Alvotech
- Comparison Chart
